Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald M Bukowski

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Expert Review of Anticancer Therapy|May 18, 2010
Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinomaRonald M Bukowski
Current Oncology Reports|February 14, 2003
Pegylated interferon alfa-2b as treatment of patients with solid tumorsRonald M Bukowski
Current Oncology Reports|February 19, 2005
Epidermal growth factor receptor expression in renal cell carcinoma: rationale for therapy with sidling blockadeRonald M Bukowski
Cancer Management and Research|December 29, 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumabRonald M Bukowski
Current Oncology Reports|February 10, 2007
Sunitinib in advanced renal cell carcinoma: new treatment option?Ronald M Bukowski
Clinical Genitourinary Cancer|October 25, 2007
Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitorsRonald M Bukowski
Frontiers in Oncology|June 2, 2012
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinomaRonald M Bukowski
Frontiers in Oncology|June 1, 2012
Genitourinary oncology: current status and future challengesRonald M Bukowski
Clinical Genitourinary Cancer|November 7, 2009
Optimizing utilization of targeted therapies in genitourinary cancersRonald M Bukowski
Journal of Oncology Practice|September 22, 2010
How I treat renal cell carcinomaRonald M Bukowski
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Expert Review of Anticancer Therapy|May 18, 2010
Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinomaRonald M Bukowski
Current Oncology Reports|February 14, 2003
Pegylated interferon alfa-2b as treatment of patients with solid tumorsRonald M Bukowski
Current Oncology Reports|February 19, 2005
Epidermal growth factor receptor expression in renal cell carcinoma: rationale for therapy with sidling blockadeRonald M Bukowski
Cancer Management and Research|December 29, 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumabRonald M Bukowski
Current Oncology Reports|February 10, 2007
Sunitinib in advanced renal cell carcinoma: new treatment option?Ronald M Bukowski
Clinical Genitourinary Cancer|October 25, 2007
Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitorsRonald M Bukowski
Frontiers in Oncology|June 2, 2012
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinomaRonald M Bukowski
Frontiers in Oncology|June 1, 2012
Genitourinary oncology: current status and future challengesRonald M Bukowski
Clinical Genitourinary Cancer|November 7, 2009
Optimizing utilization of targeted therapies in genitourinary cancersRonald M Bukowski
Journal of Oncology Practice|September 22, 2010
How I treat renal cell carcinomaRonald M Bukowski
Pageof 15